Troponin T helps physicians triage MI patients
This article was originally published in Clinica
Executive Summary
Boehringer Mannheim's troponin T test for heart muscle damage can help emergency room physicians decide how to treat heart attack patients, according to data from the 15,000-patient GUSTO III study. The trial was designed to compare a new clot-dissolving drug made by Boehringer Mannheim with Genentech's t-PA, but also included an evaluation of the rapid bedside troponin-T test to decide whether it could help stratify the patients into high and low risk groups.